¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"neoplasm circulating cells"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® neoplasm ÇÑ±Û ½Å»ý¹°
¼³¸í   
  »õ·Î »ý±ä ¹°ÁúÀ̶ó´Â ¶æÀÌ´Ù. À̰ÍÀº ´Ù¸¥ ¸»·Î ¡°Á¾¾ç(tumor)¡±À̶ó°íµµ Çϴ µ¥, ½ÇÁ¦·Î À̵éÀÇ ¸íÈ®ÇÑ ¶æÀº ¼­·Î ´Ù¸£´Ù. Á¾¾çÀ̶ó´Â ¸»Àº ¡°±× Å©±â°¡ 1cm°¡ ³Ñ´Â ÀÏÁ¾ÀǠȤ¡±À» ¸»Çϴ °ÍÀ¸·Î ÇǺΰú¿¡¼­´Â À̺¸´Ù ÀÛÀº È¤À» ±¸ÁøÀ̶ó°í ÇÏ¿© ±¸º°ÇÏ¿© ºÎ¸¥´Ù. ÇÏÁö¸¸, À̰ÍÀº ¶ÇÇÑ ÇǺλӸ¸ ¾Æ´Ï¶ó ½Åü³» ¾îµð¿¡¼­µç »ý±æ ¼ö ÀÖÀ¸¹Ç·Î ¸ðµÎ ÅëĪÇÏ¿© Á¾¾çÀ̶ó°í ºÎ¸¥´Ù. ÀÌ¿¡ ºñÇØ ¡°½Å»ý¹°¡±Àº ½Åü³» ¾ø´ø °ÍÀÌ »õ·Î »ý°Ü³µ´Ù´Â ¶æÀ¸·Î ºÙÀΠ¸»ÀÌ´Ù. ±×·¯³ª, ÀÌ µÑÀÇ °ü°è¸¦ ¸íÈ®È÷ ±ÔÁ¤ÁþÁö ¾Ê°í ÀÖÀ¸¸ç ´ë°³ °°Àº ¶æÀ¸·Î È¥¿ëµÈ´Ù.
  
  ½Å»ý¹°¿¡´Â ¡°¾ç¼º(benign)¡±°ú ¡°¾Ç¼º(malignant)¡±ÀÌ ÀÖ´Ù. ÀÌ µÑÀÇ ±¸º°Àº ¿©·¯ °¡Áö ±âÁØ¿¡ µû¸£Áö¸¸, ¶§·Î´Â ±¸º°ÀÌ ¾î·Á¿ï ¶§µµ ÀÖ´Ù. ´ë°³ ¾ç¼ºÀº »ý¸í´ÜÃàÀ» Àß ÀÏÀ¸Å°Áö ¾Ê´Â °ÍÀ¸·Î Ä¡·áÈÄ¿¡ Àç¹ßµµ Àß ÇÏÁö ¾Ê´Â´Ù. ÀÌ¿¡ ºñÇØ ¾Ç¼ºÀº Àç¹ß»Ó¸¸ ¾Æ´Ï¶ó ´Ù¸¥ ±â°üÀ¸·Î ¿Å°Ü°¡¼­ °°Àº º´º¯ÀÌ ¹ß»ýÇϴ ¡°ÀüÀÌ(metastasis)¡±Çö»óµµ ÀϾ´Ù. µû¶ó¼­ »ý¸íÀ» ´ÜÃà½Ã۴ °æ¿ì°¡ ¸¹À¸¸ç, ´ë°³ Ä¡·á°¡ ¾î·Æ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atypical glandular cells of undetermined significance
    Àǹ̹̰áÁ¤ºñÁ¤Çü»ù¼¼Æ÷
  • atypical squamous cells of undetermined significance
    Àǹ̹̰áÁ¤ºñÁ¤ÇüÆíÆò¼¼Æ÷
  • benign neoplasm
    ¾ç¼ºÁ¾¾ç
  • circulating antibody
    Ç÷ÁßÇ×ü
  • circulating blood volume
    ¼øÈ¯Ç÷¾×·®
  • circulating immune complex
    ¼øÈ¯¸é¿ªº¹ÇÕü
  • cutaneous neoplasm
    ÇǺÎÁ¾¾ç
  • cystic neoplasm
    ³¶¼º½Å»ý¹°, ³¶¼ºÁ¾¾ç
  • effective circulating volume
    À¯È¿¼øÈ¯¿ëÀû
  • neoplasm
    ½Å»ý¹°, Á¾¾ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • circulating blood volume
    ¼øÈ¯Ç÷¾×·®
  • neoplasm
    ½Å»ý¹°, Á¾¾ç
  • cystic neoplasm
    ³¶Á¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • borderline malignant epithelial ovarian neoplasm
    °æ°è¾Ç¼º»óÇdz­¼ÒÁ¾¾ç
  • cutaneous neoplasm
    ÇǺÎÁ¾¾ç
  • neoplasm
    ½Å»ý¹°, Á¾¾ç
  • circulating antibody
    Ç÷ÁßÇ×ü
  • circulating blood volume
    ¼øÈ¯Ç÷¾×·®
  • circulating immune complex
    Ç÷Á߸鿪º¹ÇÕü
  • effective circulating volume
    À¯È¿¼øÈ¯¿ëÀû
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hepatic neoplasm
    °£½Å»ý¹°(ÊÜãæßæÚª).
  • JG cells = juxtaglomerular cells
    »ç±¸Ã¼¿±¼¼Æ÷(Þêϳô÷ç¨á¬øà)
  • Alzheimer s cells
    ¾ËÂêÇÏÀ̸Ӽ¼Æ÷.
  • Alzheimers cells
    ¾ËÂêÇÏÀ̸Ӽ¼Æ÷.
  • F cells, pancreatic
    F-¼¼Æ÷(á¬øà), ÃéÀå(õýíô)ÀÇ
  • Fat cells
    Áö¹æ(ò·Û¸)¼¼Æ÷(á¬øà)
  • Fusiform cells
    ¹æÃ߻󼼯÷(Û·õßßÒá¬øà)
  • G cells
    G ¼¼Æ÷(á¬øÖ)
  • Ganglion cells
    ½Å°æÀý¼¼Æ÷(ãêÌèï½á¬øà)
  • Gastrin cells
    °¡½ºÆ®¸°¼¼Æ÷
  • Gauchers cells
    °í¼Î ¼¼Æ÷
  • Germinal cells
    ¹è¾Æ¼¼Æ÷(ÛÏä´á¬øà)
  • Giant pyramidal cells
    Å«ÇǶó¹Ô½Å°æ¿ø(ãêÌèêª)
  • Glandular cells
    ¼±¼¼Æ÷(àÍá¬øà)
  • Glial cells(neuroglia)
    ¾Æ±³¼¼Æ÷(ä¹Îïá¬øà)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • circulating antibody
    Ç÷ÁßÇ×ü(úìñéù÷ô÷).
  • circulating blood volume
    ¼øÈ¯Ç÷¾×·®(âàü»úìäûåÖ).
  • circulating granulocyte pool
    ¼øÈ¯ °ú¸³¹éÇ÷±¸ Ǫ¿ï
  • circulating immune complex (CIC)
    Ç÷Á߸鿪º¹ÇÕü
  • effective circulating volume
    À¯È¿¼øÈ¯¿ëÀû(êóüùâàü»é»îÝ)
  • water circulating mattress
    ¹°¼øÈ¯¸ÅÆ® ¸®½º.
  • water circulating mattress
    ¹°¼øÈ¯¸ÅÆ® ¸®½º.
  • cutaneous neoplasm
    ÇǺνŻý¹°, ÇǺÎÁ¾¾ç(¡­ðþåË).
  • cutaneous neoplasm
    ÇǺνŻý¹°, ÇǺÎÁ¾¾ç(¡­ðþåË)
  • hepatic neoplasm
    °£½Å»ý¹°(ÊÜãæßæÚª).
  • lymphoplasmacytic neoplasm
    ¸²ÇÁÇüÁú¼¼Æ÷¼º ½Å»ý¹°
  • malignant neoplasm
    ¾Ç¼º½Å»ý¹°(¡­ãæßæÚª).
  • malignant neoplasm
    ¾Ç¼º½Å»ý¹°(¡­ãæßæÚª)
  • neoplasm =neoplasma
    ½Å»ý¹° Á¾¾ç(¡­ðþåË)
  • organoid neoplasm
    ±â°ü¾ç½Å»ý¹°(ÐïίåÆãæßæÚª)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Tympanic air cells
    °í½Ç¹úÁý
    [¿¾ ¿ë¾î] °í½ÇºÀ¼Ò
  • Tympanic cells
    °í½Ç¹úÁý
    [¿¾ ¿ë¾î] °í½ÇºÀ¼Ò
  • Air cells of auditory tube
    ±ÍÀεΰü¹úÁý
    [¿¾ ¿ë¾î] À̰üºÀ¼Ò
  • Mastoid air cells
    ²ÀÁö¹úÁý
    [¿¾ ¿ë¾î] À¯µ¹ºÀ¼Ò
  • Mastoid cells
    ²ÀÁö¹úÁý
    [¿¾ ¿ë¾î] À¯µ¹ºÀ¼Ò
  • Ethmoidal cells
    ¹úÁý
    [¿¾ ¿ë¾î] »ç°ñºÀ¼Ò
  • Epithelial cells
    »óÇǼ¼Æ÷
    [¿¾ ¿ë¾î] »óÇǼ¼Æ÷
  • Anterior cells
    ¾Õ¹úÁý
    [¿¾ ¿ë¾î] ÀüºÀ¼Ò
  • Spermatogenic cells
    Á¤Àڹ߻ý¼¼Æ÷
    [¿¾ ¿ë¾î] Á¤¼¼Æ÷
  • Connective tissue cells
    °áÇÕÁ¶Á÷¼¼Æ÷
    [¿¾ ¿ë¾î] °áÇÕÁ¶Á÷¼¼Æ÷
  • Posterior cells
    µÚ¹úÁý
    [¿¾ ¿ë¾î] ÈĺÀ¼Ò
  • Middle cells
    Áß°£¹úÁý
    [¿¾ ¿ë¾î] ÁߺÀ¼Ò
  • Blood cells
    Ç÷¾×¼¼Æ÷ [Ç÷±¸]
    [¿¾ ¿ë¾î] Ç÷¾×¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • circulating water bath
    ¼øÈ¯ ¼öÁ¶(âàü»â©ðË)
  • endothelial cells
    ³»ÇǼ¼Æ÷ (Ò®ù«á¬øà)
  • HeLa cells
    HeLa ¼¼Æ÷(á¬øà)
  • killer T cells
    »ì(߯) T¼¼Æ÷(á¬øà)
  • Kupffer cells
    ÄíÆÛ ¼¼Æ÷(á¬øà)
  • regulatory T cells
    Á¶Àý(ðàï½) T¼¼Æ÷(á¬øà)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ethmoidal air cells
    »ç°ñ¹úÁý, »ç°ñºÀ¼Ò
  • malignant neoplasm
    ¾Ç¼º½Å»ý¹°
  • neoplasm
    ½Å»ý¹°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CEA Carcino-Embryonic Antigen [HP 1825-6]
  ; Oncofetal Antigens
  ; Glycopro...
LAK T cells Lymphokine Activated Killer T cells
SRC sedimented red cells; sheep red cells
UC ulcerative colitis; ultracentrifugal; umbilical cord; unchanged; unclassifiable; unconscious; undiff...
CBN cannabinol; central benign neoplasm; Commission on Biological Nomenclature
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SMN Second Malignant Neoplasm
CPC Circulating progenitor cells
C Circulating
cICAM-1 Circulating ICAM-1
CIC Circulating Immune Complexes
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Rouget's cells
    Rouget ¼¼Æ÷
  • circulating antibasement membrane antibody
    ¼øÈ¯ Ç×±âÀú¸· Ç×ü
  • circulating anticoagulant
    ¼øÈ¯¼º Ç×ÀÀ°íÁ¦
  • circulating blood volume
    ¼øÈ¯ Ç÷¾×·®
  • circulating pool
    ¼øÈ¯ Ç®
  • disseminated malignant neoplasm
    ÆÛÁ® ÀÖ´Â ¾Ï
  • hematologic neoplasm
    Ç÷¾× ½Å»ý¹°
  • immunologic neoplasm
    ¸é¿ªÇÐÀû ½Å»ý¹°, ¸é¿ªÇÐÀû Á¾¾ç
  • malignant neoplasm
    ¾Ç¼º ½Å»ý¹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
neoplasm circulating cells Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumours.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
thymic factor, circulating <chemical> A thymus-dependent nonapeptide found in normal blood. Stimulates the formation of e rosettes and is believed to be involved in T-cell differentiation.
Chemical name: Thymulin
(12 Dec 1998)
antibodies, neoplasm Immunoglobulins induced by antigens specific for tumours other than the normally occurring histocompatibility antigens.
(12 Dec 1998)
antigens, neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumour cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.
(12 Dec 1998)
brain neoplasm Neoplasms of the part of the central nervous system contained within the cranium.
(12 Dec 1998)
genes, structural, neoplasm DNA sequences that code for RNA and for the proteins required for the enzymatic and structural function of neoplastic cells.
(12 Dec 1998)
mucinous cystic neoplasm of pancreas <radiology> = macrocystic adenoma of pancreas, cystadenoma / cystadenocarcinoma, M:F = 1:9, 40-60 years of age, malignant or pre-malignant, large mass (mean 12 cm), multilocular cysts, thick septations, tail / body in 85% (unlike adenocarcinoma and microcystic adenoma), hypo-/avascular, Differential diagnosis: panc pseudocyst, ** Cf: microcystic adenoma
(12 Dec 1998)
histoid neoplasm Old term for a neoplasm characterised by a cytohistologic pattern that closely resembles the tissue from which the neoplastic cells are derived.
(05 Mar 2000)
neoplasm <oncology, pathology> New and abnormal growth of tissue, which may be benign or cancerous.
(16 Dec 1997)
neoplasm: gallium imaging <radiology> Useful: Hodgkin disease and histiocytic form of NHL poor sensitivity below the diaphragm, Burkitt lymphoma: almost 100% sensitivity, hepatoma: 90% sensitivity, melanoma: 90% sensitivity, leukaemia possibly useful: NHL: good for large and mediastinal lesions, nodal metastases from seminoma and embryonal cell carcinoma: 87% sensitivity, non-small cell lung CA: 85% sensitive not useful: head and neck, GI (especially adenocarcinoma), breast, gynaecological, kiddie tumours see: gallium: indications
(12 Dec 1998)
neoplasm invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
(12 Dec 1998)
neoplasm metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. The ability to metastasize is characteristic of all malignant neoplasms.
(12 Dec 1998)
neoplasm recurrence, local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
(12 Dec 1998)
neoplasm regression, spontaneous Disappearance of a neoplasm or neoplastic state without the intervention of therapy.
(12 Dec 1998)
neoplasm, residual Remnant of a tumour or cancer after primary, potentially curative therapy. (dr. Daniel masys, written communication)
(12 Dec 1998)
neoplasm seeding The local implantation of tumour cells by contamination of instruments and surgical equipment during and after surgical resection, resulting in local growth of the cells and tumour formation.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Neoplasm Circulating Cells - »õâ Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors.
    Synonyms : Cells, Neoplasm Circulating, Circulating Cells, Neoplasm, Cell, Embolic Tumor, Cell, Neoplasm Circulating, Cells, Embolic Tumor, Embolic Tumor Cell, Embolisms, Tumor, Neoplasm Circulating Cell, Tumor Cell, Embolic, Tumor Embolism, Tumor Embolisms
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gray cells
    ³ú;³ú¼ö;µÎ³ú;Áö´É;Áö¼º
  • neoplasm
    (º´¸®)ü³»¿¡ »ý±â´Â ½Å»ý¹°;(ƯÈ÷)Á¾¾ç
  • circulating
    ¼øÈ¯ÇÏ´Â;¼øÈ¸ÇÏ´Â
  • circulating capital
    À¯µ¿ ÀÚº»
  • circulating decimal
    ¼øÈ¯ ¼Ò¼ö
  • circulating library
    (À¯·áÀÇ È¸¿øÁ¦)´ëÃâ µµ¼­°ü;¼øÈ¸ µµ¼­°ü;ȸ¶÷¹®°í;´ëº»Áý
  • circulating medium
    ÅëÈ­
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á